Ann: Dispute with Solagran Limited , page-13

From what I can see - BPO have pretty much decided not to pursue that claim.

The issue raised by BPO in yesterday's announcement is purely on the 'manufacture' and 'extraction' meaning. No mention of SLA's provision of BioA at cost or above cost.

Anyhow like you said earlier.. who knows what will happen when things get into court. But it would be useful if BPO's claims actually made sense, which it currently does not to many people. I have not seen one post in any austrlaian stock forums which explain a good rationale or logic behind BPO's claims.

Would appreciate it if somebody could give me one. Because I am actually interested to see. I would just hate to see BPO waste the few hundred grand they had left to initiate legal proceedings just to ensure that SLA did not dump BPO shares prior or during a much needed cap raising for BPO.

I dont see BPO being able to raise funds in any other way other than to do a placement to institutions/sophisticated investors at 1c or lower. Does not look good in terms of dilution.